GlassScriptPhysician profile
Jay R Moodley
NPI 1609805126
$2,654.49
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $260 · 2021: $463 · 2022: $536 · 2023: $429 · 2024: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.01 | 2019-2024 | |
| Amgen INC. | $306.78 | 2019-2024 | Evenity, Prolia |
| Channel Medsystems, INC. | $203.09 | 2022-2024 | |
| Hologic Sales and Service, LLC | $170.78 | 2019-2024 | Acessa Provu System |
| Astellas Pharma US INC | $126.95 | 2022-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $117.85 | 2022-2024 | |
| Evofem Biosciences, INC. | $103.66 | 2021-2022 | |
| Organon LLC | $102.00 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $82.84 | 2019-2024 | Slynd |
| Exact Sciences Corporation | $78.74 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $75.00 | 2019-2022 | |
| Minerva Surgical, INC | $73.89 | 2020-2022 | |
| Avion Pharmaceuticals | $72.77 | 2019-2022 | |
| Biogen, INC. | $70.99 | 2024 | |
| Myovant Sciences INC. | $68.73 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $49.12 | 2019-2021 | |
| Becton, Dickinson and Company | $45.50 | 2019-2024 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $40.93 | 2019 | |
| Shield Therapeutics INC | $32.82 | 2023-2024 | Accrufer |
| Roche Diagnostics Corporation | $22.49 | 2019 | |
| Boston Scientific Corporation | $18.39 | 2019 | |
| Scynexis, INC. | $17.74 | 2022 | |
| Avanos Medical | $16.03 | 2022 | |
| Coopersurgical, INC. | $15.00 | 2022 | |
| Daiichi Sankyo INC. | $14.38 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.16 | 2023 | Seglentis |
| Agile Therapeutics, INC. | $13.50 | 2021 | |
| Aspira Women'S Health INC | $12.99 | 2021 | |
| Duchesnay USA Incorporated | $12.72 | 2019 | |
| Lupin INC. | $12.57 | 2019 | |
| Merck Sharp & Dohme LLC | $12.40 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Moodley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.